Who
Deborah M. Messemer
Director
Company insider
Files Form 4 as: Director, Tpg; Director, Allogene Therapeutics; Director, PayPal Holdings.
In numbers
- Trades disclosed
- 38
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $1.4M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 15 Oct 2018
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code A | —4,181 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code A | —4,181 | filing |
| 18 Jun 2026filed 23 Jun 2026 | ALLO Allogene Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,400 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | ALLO Allogene Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,400 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | PYPL PayPal HoldingsPayments & Processors | SEC FORM 4 Code A | —6,275 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | PYPL PayPal HoldingsPayments & Processors | SEC FORM 4 Code A | —6,275 at $0.00 | filing |
| 16 Jul 2025filed 17 Jul 2025 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Sold | $101K1,796 at $56.32 | filing |
| 15 Jul 2025filed 17 Jul 2025 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code A | —2,762 | filing |
| 18 Jun 2025filed 23 Jun 2025 | ALLO Allogene Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,400 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | ALLO Allogene TherapeuticsBiotechnology | SEC FORM 4 Sold | $52K36,885 at $1.42 | filing |
| 6 Jun 2025filed 6 Jun 2025 | PYPL PayPal HoldingsPayments & Processors | SEC FORM 4 Sold | $277K3,795 at $73.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | PYPL PayPal HoldingsPayments & Processors | SEC FORM 4 Code A | —3,795 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | ALLO Allogene TherapeuticsBiotechnology | SEC FORM 4 Sold | $32K13,313 at $2.43 | filing |
| 14 Jan 2025filed 15 Jan 2025 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Sold | $105K1,695 at $61.91 | filing |
| 9 Dec 2024filed 10 Dec 2024 | ALLO Allogene TherapeuticsBiotechnology | SEC FORM 4 Sold | $20K9,136 at $2.18 | filing |
| 17 Jul 2024filed 17 Jul 2024 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Sold | $190K4,089 at $46.55 | filing |
| 15 Jul 2024filed 17 Jul 2024 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code A | —3,592 | filing |
| 18 Jun 2024filed 20 Jun 2024 | ALLO Allogene TherapeuticsBiotechnology | SEC FORM 4 Sold | $43K18,641 at $2.28 | filing |
| 5 Jun 2024filed 7 Jun 2024 | ALLO Allogene TherapeuticsBiotechnology | SEC FORM 4 Code A | —122,950 at $0.00 | filing |
| 24 May 2024filed 24 May 2024 | PYPL PayPal HoldingsPayments & Processors | SEC FORM 4 Sold | $273K4,422 at $61.65 | filing |
News
PayPal (PYPL) Projected to Announce Quarterly Earnings on TuesdayPYPL · dailypolitical.com · 20 Oct 2026Here Are Monday's Top Wall Street Analyst Research Calls: Ameriprise Financial, Boyd Gaming, CoreWeave, Datadog, Intel, JetBlue Airways, PayPal Holdings, Pinterest, Whirlpool, and MorePYPL · aol.com · 19 Oct 2026PayPal (NASDAQ: PYPL) Rallies On AI Shopping Push As Fiserv (NYSE: FISV) Faces Price Target Cuts And CFPB Targets DebankingPYPL · foreignpolicyjournal.com · 18 Oct 2026Comparing eXoZymes (NASDAQ:EXOZ) and Allogene Therapeutics (NASDAQ:ALLO)ALLO · dailypolitical.com · 16 Oct 2026Head to Head Comparison: Generate Biomedicines (NASDAQ:GENB) vs. Allogene Therapeutics (NASDAQ:ALLO)ALLO · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Deborah M. Messemer; 5 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.